Clinical Trials on Hemostatis in Italy

Total 331 results

IRCCS San Raffaele

Recruiting

Clinical Study of Patients Treated With PuraBond Haemostatic Agent During Abdominal Aorta Open Repair

Hemostatic

Italy
Cardiochirurgia E.H.

Terminated

Blood Sparing Strategies: Omni-stat Routinary Use in Cardiac Surgery. A Prospective Randomized Study.

Hemostasis

Italy
Fondazione Policlinico Universitario Agostino Gemelli...
Baxter Healthcare Corporation

Unknown

Efficacy and Tolerability of Hemopatch After Hepatic Resection

Hepatectomy | Hemostasis | Cancer, Metastatic

Italy
Centro Cardiologico Monzino

Recruiting

Markers of Inflammation and of the Pro-thrombotic State in Hospital Shift and Day Workers (IPNO)

Inflammation | Sleep Disorder | Hemostatic Disorder | Shift-Work Related Sleep Disturbance

Italy
Fondazione Policlinico Universitario Agostino Gemelli...

Completed

Blood Coagulation Profile After Liver Resection.

Coagulation Disorder

Italy
HemoSonics LLC
IRCCS Policlinico S. Donato

Completed

Comparison of Two Point-of-care Devices for Viscoelastic Hemostasis Assays

Coagulation Disorder

Italy
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Multinational Study to Evaluate the Effects of a 28-Day Oral Contraceptive on Hemostatic Parameters in Healthy Women

Oral Contraceptive | Hemostasis

Germany, Israel, Italy, Spain
Fondazione EMN Italy Onlus

Completed

RMPT for Relapsed/Refractory Multiple Myeloma (RMPT)

Multiple Myeloma

Italy
Quovadis Associazione

Recruiting

MAC Project, Monitoring of AntiCoagulant Therapies (MAC) (MAC)

Anticoagulants and Bleeding Disorders

Italy
Emiliano Petrucci

Completed

Blood Gas and Bleeding Disorders in Healthy Volunteers Exposed to Nitroglycerin and Nitrogen Compounds

Bleeding Disorder | Disorder of Blood Gas

Italy
University of Turin, Italy

Unknown

Role of Thromboelastography in Septic Shock

Sepsis | Bleeding Disorder

Italy
Teva Women's Health

Completed

A Multicenter Study to Evaluate the Effects of a 91-Day Extended Cycle Oral Contraceptive on Hemostatic Parameters in Healthy Women

Oral Contraceptive | Hemostasis

United States, Italy
European Myeloma Network
Fondazione EMN Italy Onlus

Completed

Study of Carfilzomib, Cyclophosphamide and Dexamethasone in Newly Diagnosed Multiple Myeloma Patients (CCD)

Multiple Myeloma

Italy
Mario Boccadoro

Completed

Validation of a Personalised Medicine Tool for Multiple Myeloma That Predicts Treatment Effectiveness in Patients (MMpredict)

Multiple Myeloma

Italy
Fondazione EMN Italy Onlus

Completed

Velcade, Melphalan, Prednisone And Thalidomide Versus Velcade, Melphalan, Prednisone in Multiple Myeloma Patients

Multiple Myeloma

Italy
Italfarmaco

Terminated

Phase II Clinical Trial of ITF2357 In Patients With Relapsed/Refractory Multiple Myeloma

Multiple Myeloma

Italy
Genenta Science
IRCCS San Raffaele

Terminated

A Phase I/II Study Evaluating Temferon in Multiple Myeloma Patients With Early Relapse After Front Line Therapy (TEM-MM)

Multiple Myeloma

Italy
Gruppo Italiano Studio Linfomi

Completed

A Randomized Study With Oral Melphalan + Prednisone (MP) Versus Melphalan, + Prednisone + Thalidomide (MPT) for Newly Diagnosesd Elderly Patients With Multiple Myeloma

Multiple Myeloma

Italy
Fondazione EMN Italy Onlus

Completed

Detection of Poor Mobilizer (PM) in Multiple Myeloma (MM) Patients

Multiple Myeloma

Italy
Stichting European Myeloma Network
Fondazione EMN Italy Onlus

Active, not recruiting

Study of Weekly Carfilzomib, Cyclophosphamide and Dexamethasone In Newly Diagnosed Multiple Myeloma Patients (wCCyd) (wCCyd)

Multiple Myeloma

Italy
Fondazione EMN Italy Onlus

Active, not recruiting

Cyclophosphamide, Lenalidomide and Dexamethasone (CRD) Versus Melphalan (200 mg/m2) Followed By Autologous Stem Cell Transplant (ASCT) In Newly Diagnosed Multiple Myeloma Subjects

Multiple Myeloma

Italy
Azienda Ospedaliera San Giovanni Battista

Completed

Serum Free Light Change in Multiple Myeloma

Multiple Myeloma

Italy
Azienda Ospedaliera San Giovanni Battista

Unknown

Tandem Autologous- Nonmyeloablative Allogeneic Transplant for Newly Diagnosed Multiple Myeloma (Trapianto Tandem Autologo-Allogenico Non Mieloablativo Nel Mieloma Alla Diagnosi)

Multiple Myeloma

Italy
Università Politecnica delle Marche

Completed

Maintenance Therapy After Thalidomide-Dexamethasone(ThaDD) for Multiple Myeloma(MM)

Multiple Myeloma

Italy
University of Campania "Luigi Vanvitelli"
Monaldi Hospital

Unknown

Atrial Fibrillation Research Database

Atrial Fibrillation | Anticoagulants and Bleeding Disorders

Italy
Baxter Healthcare Corporation

Completed

Hemopatch Performance Evaluation: A Prospective Observational Registry

Air Leakage | Dura Mater Nick Cut or Tear | Hemostatis | Body Fluid Leakage

Germany, Spain, Czechia, Italy, Austria
Gruppo Italiano Studio Linfomi

Unknown

Study of Bendamustine, Lenalidomide and Low-dose Dexamethasone, for the Treatment of Patients With Relapsed Myeloma

Multiple Myeloma

Italy
Azienda Ospedaliera San Giovanni Battista

Unknown

Hematopoietic Stem Cell Transplantation in Myeloma

Multiple Myeloma

Italy
Mario Boccadoro

Completed

STUDY THAT COMPARE 3 ARM: MLN9708 DEXAMETHASONE, MLN9708 CYCLOPHOSPHAMIDE AND DEXAMETHASONE, MLN9708 THALIDOMIDE AND DEXAMETHASONE FOLLOWED BY MAINTENANCE WITH MLN9708 IN NEWLY DIAGNOSED ELDERLY MULTIPLE MYELOMA PATIENTS

Multiple Myeloma

Italy
European Myeloma Network
Fondazione EMN Italy Onlus

Completed

Subcutaneous Velcade Plus Oral Melphalan and Prednisone or Plus Cycloposphamide and Prednisone or Plus Prednisone

Multiple Myeloma

Italy
European Myeloma Network
University of Turin, Italy

Completed

Phase I/II Study of Carfilzomib, Pomalidomide and Dexamethasone in Relapsed And/Or Refractory Multiple Myeloma Patients (CPD) (CPD)

Multiple Myeloma

Italy
Fondazione EMN Italy Onlus

Active, not recruiting

STUDY TO DETERMINE THE EFFICACY AND SAFETY OF STANDARD SCHEDULE VERSUS A NEW ALGORITHM OF DOSE REDUCTIONS IN ELDERLY AND UNFIT NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS RECEIVING LENALIDOMIDE PLUS STEROIDS

Multiple Myeloma

Italy
Fondazione EMN Italy Onlus

Completed

Safety And Efficacy Of Lenalidomide As Maintenance Therapy In Patients With Newly Diagnosed Multiple Myeloma Following A Tandem Autologous-Allogeneic Transplant

Multiple Myeloma

Italy
Fondazione Policlinico Universitario Agostino Gemelli...

Completed

Counseling Intervention in Hereditary Hemorrhagic Telangiectasia in the COVID Era.

Hereditary Hemorrhagic Telangiectasia

Italy
Azienda Ospedaliera San Giovanni Battista

Unknown

Non-Myeloablative Allogeneic Transplantation From Unrelated Donors in Multiple Myeloma

Multiple Myeloma

Italy
Azienda Ospedaliera Universitaria Senese
Janssen-Cilag S.p.A.

Recruiting

Study of Daratumumab in Multiple Myeloma (MM) Patients in >VGPR/MRD-positive (DART4MM)

Myeloma Multiple

Italy
Fondazione EMN Italy Onlus

Completed

Monitoring of Deep of Response During Lenalidomide Maintenance in MM Patients Achieving at Least Very Good Partial Response (MRD) (MRD)

Multiple Myeloma

Italy
Michele Cavo
Janssen-Cilag S.p.A.

Unknown

VELCADE-Thalidomide-Dexamethasone (VTD) vs Thalidomide-Dexamethasone (TD) Incorporated Into Double Autotransplantation for Untreated Multiple Myeloma (MM)

Multiple Myeloma

Italy
Regina Elena Cancer Institute
University of Rome Tor Vergata; Campus Bio-Medico University; Sant'Eugenio Hospital...

Recruiting

Transcriptomics and Epigenetics Analysis in Drug-Resistance of Multiple Myeloma (TEDROMM)

Multiple Myeloma

Italy
University of Turin, Italy

Recruiting

STUDY COMPARING TWO STANDARD TREATMENTS IN AUTOLOGOUS STEM CELL TRANSPLANTATION INELIGIBLE POPULATION AFFECTED BY MULTIPLE MYELOMA

Multiple Myeloma

Italy
Scientific Institute San Raffaele
Università Vita-Salute San Raffaele

Recruiting

Dynamics of Platelet Activation in Patients With Ventricular Assist Device (VAD) (PASVAD)

Thrombosis | Blood Coagulation Disorder | Platelet Thrombus | Platelet Dysfunction Due to Aspirin | Failure;Ventricular

Italy
Mario Boccadoro

Active, not recruiting

Immune Profiling in Multiple Myeloma

Multiple Myeloma

Italy
IRCCS San Raffaele

Completed

Role of18F-FDG PET-CT for Assessing and Predicting Response to Daratumumab and for Prognosis With Multiple Myeloma

Multiple Myeloma

Italy
Federico II University

Completed

Optical Coherence Tomography (OCT) and OCT Angiography(OCTA) Deep Learning in Waldenström's Macroglobulinemia Patients (OCTA)

Waldenstrom Macroglobulinemia

Italy
Azienda Ospedaliera San Giovanni Battista

Completed

Allogeneic Bone Marrow Transplantation From Unrelated Donors in Multiple Myeloma (MM2011)

Multiple Myeloma | Allogeneic Transplantation

Italy
Regina Elena Cancer Institute

Recruiting

Inhibition of Che-1/AATF as a New Tool in Multiple Myeloma Treatment (AATF/Che-1)

Multiple Myeloma

Italy
A.O. Ospedale Papa Giovanni XXIII

Withdrawn

Use of Viscoelastic Tests in the Treatment of Traumatic Induced Coagulopathy: a Pragmatic Randomized Clinical Trial. (VISCOTRAUMA)

Trauma, Multiple | Coagulopathy | Massive Hemorrhage

Italy
Fondazione Policlinico Universitario Agostino Gemelli...

Recruiting

Daratumumab-containing Induction Effects on Stem Cells Mobilization, colLection and Engraftment in Newly Diagnosed Multiple MyelomA Patients. (DILEMMA)

Multiple Myeloma | Daratumumab | Autologous Stem Cell Transplantation | Leukapheresis

Italy
Fondazione EMN Italy Onlus

Terminated

Dasatinib in Combination With Melphalan and Prednisone to Treat Relapsed and Refractory Multiple Myeloma Patients (D-MP)

Myeloma

Italy
Fondazione EMN Italy Onlus

Active, not recruiting

Lenalidomide Melphalan and Prednisone Versus High Dose Melphalan in Newly Diagnosed Multiple Myeloma Patients (MPRvsMEL200)

Multiple Myeloma | Newly Diagnosed Patients

Italy

3

Subscribe